Doravirine, Islatravir

6 trials

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

7 Countries

Phase III

Phase III: 6

Sponsors using this IMP

Merck Sharp & Dohme LLC 6

All trials

6 total

A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir Not authorised

2022-502079-49-00 Phase III 4 countries Merck Sharp & Dohme LLC
A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Not authorised

2022-502099-22-00 Phase III 6 countries Merck Sharp & Dohme LLC
A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised

2022-502126-40-00 Phase III 6 countries Merck Sharp & Dohme LLC
A clinical study of people with HIV-1 who take antiretroviral therapy and switch their treatment to a combination of doravirine and islatrav… Not authorised

2022-502127-22-00 Phase III 3 countries Merck Sharp & Dohme LLC
A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Ended

2022-502099-22-01 Phase III 3 countries Merck Sharp & Dohme LLC
DOR/ISL Open-label Rollover Trial Ended

2024-512215-53-00 Phase III 2 countries Merck Sharp & Dohme LLC

Showing 1–6 of 6 trials

← All drugs A–Z